- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02613260
Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System
Study Overview
Detailed Description
Rationale: Since uptake of colorectal cancer (CRC) screening is suboptimal in the SF safety-net system and access to care may be limited, novel models of health care delivery are warranted. The overall hypothesis is that a centralized panel management model with mailed fecal immunochemical test (FIT) will be effective at increasing the uptake of CRC screening and could be developed and sustained within the typical parameters of cost-effectiveness and budget impact analyses. Barriers to immunization of adults include missed opportunities during visits, limited access to providers, and provider and patient beliefs of efficacy.
Design: To rigorously examine the benefit of the centralized panel management to improve uptake of CRC screening with mailed FIT, the electronic health system will be used to identify eligible patients who are not up-to-date with CRC screening. Broadly, patients will be randomized 1:1 to usual care or intervention arm, stratified by clinic, gender, prior screening, and race to receive mailed FIT kits + usual care versus usual care alone. The cost-effectiveness of no screening, usual care, and centralized management with mailed FIT outreach will be compared using mathematical simulation models.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94110
- University of California, San Francisco-San Francisco General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Asymptomatic men and women
- 50 to 75 years of age
Exclusion Criteria:
- Personal history of polyps requiring colonoscopic surveillance
- Homeless
- Severe co-morbidities limiting life expectancy e.g., advanced stage cancer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual Care
Patients in this study arm will receive usual care from their primary care clinic.
|
|
Experimental: FIT Outreach + Usual Care
Patients in this study arm will receive usual care at their primary care clinic and the intervention.
|
This arm will consist of priming patients with a postcard and a possibly a phone call two weeks prior to them being mailed a FIT kit.
The FIT kits will be mailed to the patients with a letter from their clinic's care team informing them why they should complete the FIT and wordless instructions to help them complete the FIT.
Two weeks after the FIT kit is mailed the patients that have not returned the kit will receive up to two reminder calls.
During the phone calls the outreach workers will use health coaching techniques to encourage patients to complete the FIT.
All written materials have been translated into English and Chinese and during phone calls patients will be spoken to in the language that they are most comfortable using.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Completion of FIT- one year
Time Frame: One year
|
The primary outcome is the completion rate for CRC screening one-year after randomization between mailed FIT outreach and usual care.
|
One year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incomplete FIT- 28 days
Time Frame: 28 days
|
Of the patients mailed the FIT kit the number of patients that have not completed their FIT.
|
28 days
|
FIT Positive
Time Frame: 1 year
|
Among the patients that have completed the FIT the percentage that had a positive FIT test.
|
1 year
|
Completed Colonoscopy
Time Frame: One year
|
Of the patients that had a positive FIT the percentage of patients that received a colonoscopy.
|
One year
|
Colonoscopy Findings
Time Frame: One year
|
Of the patients that received a colonoscopy what were the findings (rate of any adenoma, advanced neoplasia, and colorectal cancer).
|
One year
|
Cost
Time Frame: Two years
|
How much the program costed to start and the costs throughout program implementation.
|
Two years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ma Somsouk, MD, University of California, San Francisco
Publications and helpful links
General Publications
- Lee B, Keyes E, Rachocki C, Grimes B, Chen E, Vittinghoff E, Ladabaum U, Somsouk M. Increased Colorectal Cancer Screening Sustained with Mailed Fecal Immunochemical Test Outreach. Clin Gastroenterol Hepatol. 2022 Jun;20(6):1326-1333.e4. doi: 10.1016/j.cgh.2021.07.022. Epub 2021 Jul 16.
- Wang A, Rachocki C, Shapiro JA, Issaka RB, Somsouk M. Low Literacy Level Instructions and Reminder Calls Improve Patient Handling of Fecal Immunochemical Test Samples. Clin Gastroenterol Hepatol. 2019 Aug;17(9):1822-1828. doi: 10.1016/j.cgh.2018.11.050. Epub 2018 Nov 29.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-14861
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colonic Neoplasms
-
Imperial College LondonCompletedColonic Diseases | Colonic Polyp | Colonic Neoplasms | Colonic Cancer | Colonic Adenocarcinoma | Colonic Adenoma | Colonic Carcinoma | Colonic Dysplasia | Colon Hyperplastic PolypUnited Kingdom
-
Hospital Universitario de MóstolesCompletedColonic Polyp | Colonic Neoplasms | Colonic Cancer
-
Changi General HospitalNational University Hospital, Singapore; Singapore General Hospital; Tan Tock...CompletedColonic Polyp | Colonic Neoplasms | Colonic DysplasiaSingapore
-
Oxford University Hospitals NHS TrustCompletedRectal Cancer | Ulcerative Colitis | Colonic Cancer | Colonic DiverticulumUnited Kingdom
-
Institute of Gastroenterology and Advance EndoscopyNot yet recruitingColonic Polyp | Colonic Neoplasms | Colonic Adenoma | Colonic DiseaseArgentina
-
The University of Hong KongRecruitingColonic Polyp | Colonic Cancer | Colonic AdenomaHong Kong
-
University of Turin, ItalyNot yet recruitingColonic Polyp | Colonic Neoplasms | Colonic Dysplasia
-
The University of Hong KongUnknownColonic Polyps | Colonic CancersHong Kong
-
UNC Lineberger Comprehensive Cancer CenterPfizer; AmgenActive, not recruitingColon Cancer | Colonic Cancer | Cancer of the Colon | Colon Neoplasms | Neoplasms, ColonicUnited States
-
Chinese University of Hong KongCompleted
Clinical Trials on FIT Outreach
-
University of California, San DiegoNational Cancer Institute (NCI)Enrolling by invitationColorectal CancerUnited States
-
University of PennsylvaniaCompleted
-
The New Model of Care, Hail Health ClusterHealth Holding Company, Saudi Arabia; Hail Health Cluster, Saudi ArabiaRecruitingColorectal Neoplasms | Colorectal CancerSaudi Arabia
-
University of PennsylvaniaCompletedCancer of the Colon
-
Harvard Medical School (HMS and HSDM)Humana Co.Ltd.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Kaiser PermanenteCompleted
-
Whisper.aiSan Jose State UniversityRecruitingHearing LossUnited States
-
Massachusetts General HospitalNot yet recruitingFood Insecurity | Nutrition, Healthy | Vulnerable Populations
-
University of California, IrvineCompletedCardiovascular Diseases | Cardiovascular Risk FactorUnited States
-
University of Sao Paulo General HospitalUniversity of Sao Paulo; University of East Anglia; University of Cape Town; Medical... and other collaboratorsUnknownHeart Failure | Hypertension | Diabetes Mellitus | Ischemic Heart Disease | Cerebrovascular DiseaseBrazil